Serum Cystatin C as a Potential Marker for Glomerular Filtration Rate in Patients with Cholangiocarcinoma

Background: Cholangiocarcinoma (CCA) is the second most common primary hepatobiliary cancer. These patients have meager prognosis and short-term survival. Precise assessment of glomerular filtration rate is a fundamental aspect of clinical care in cancer patients. Cystatin C has been proposed to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciin, Mang Ngaih, Proungvitaya, Tanakorn, Limpaiboon, Temduang, Roytrakul, Sittiruk, Cha’on, Ubon, Tummanatsakun, Doungdean, Proungvitaya, Siriporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521392/
https://www.ncbi.nlm.nih.gov/pubmed/33024521
http://dx.doi.org/10.18502/ijhoscr.v14i3.3723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521392/
https://www.ncbi.nlm.nih.gov/pubmed/33024521
http://dx.doi.org/10.18502/ijhoscr.v14i3.3723

Ejemplares similares